Bristol-Myers Squibb Company
Pyrrolidine GPR40 modulators
Last updated:
Abstract:
The present invention provides compounds of Formula (I): ##STR00001## or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, or a solvate thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments.
Status:
Grant
Type:
Utility
Filling date:
6 Dec 2018
Issue date:
21 Jul 2020